Stocks to sell

The economic numbers keep rolling in and they continue to look good. Jobless claims are falling. Hiring demand is rising. There’s money in the system. It’s all very attractive. But that’s what we’re seeing right now. The market isn’t really interested in right now. It’s looking at right now and making predictions on six months

Despite intense competition and the easing of the COVID pandemic restrictions, Zoom Video Communications (NASDAQ:ZM) is still zooming. ZM stock? Not so much. Zoom’s first fiscal quarter (April) results justified all the past faith that investors put into it. The company earned $227 million, 74 cents per share fully diluted, on revenue of $947 million.

If you’re a spiritually-minded person perhaps you can send up thoughts and prayers for people who own Workhorse Group (NYSE:WKHS) stock. Source: rblfmr / Shutterstock.com The company has limited revenue and even more limited prospects for the same. It faces scalability concerns in a sector with growing competition, and yet there are diamond hands within the

InvestorPlace columnist Brenden Rearick recently discussed Castor Maritime’s (NASDAQ:CTRM) first profitable quarter since 2019. Interestingly, despite the positive results, CTRM stock fell on the news.  Source: Pavel Kapysh / Shutterstock.com Rearick points out that the company is ready to take advantage of the “strong demand for dry bulk transportation services” with 18 dry bulk carriers

Given the recent short squeeze attempts on meme stocks like AMC (NYSE:AMC) and GameStop (NYSE:GME), it’s no surprise that investors have been searching for juice among similar stocks with high short interest. Enter Churchill Capital Corp IV (NYSE:CCIV), a high profile SPAC (Special Purpose Acquisition Company), which currently has 26% of its float in short

I like cruising. In fact, I especially like the Celebrity line from Royal Caribbean (NYSE:RCL). But I would no more buy RCL stock than I would Gamestop (NYSE:GME). The numbers just don’t make sense. Source: ImagineStock / Shutterstock.com Royal Caribbean opened for trade on Jun. 11 near $89 per share. That’s a market capitalization of

Naked Brand (NASDAQ:NAKD) released its latest prospectus on May 18 showing that the company now has roughly 813.8 million shares outstanding. This allows us to calculate its actual market value. Currently, NAKD has a market cap of $626 million at yesterday’s price of 77 cents for NAKD stock. As a result, the stock looks to be

There are multiple reasons to be bearish on Canoo (NASDAQ:GOEV) stock. And there are a lot of reasons to believe Canoo will lag behind the broader electric vehicle market for the foreseeable future as well. I’ll get into those too. Source: Shutterstock But one of the most current and powerful forces that will keep GOEV

Biogen (NASDAQ:BIIB) stock ripped higher this week on approval of its Alzheimer’s drug, Aduhelm. Source: PictureDesignSwiss / Shutterstock.com Analysts seemed taken with Biogen’s proposed pricing, $56,000 per year. It’s based on the cost of Alzheimer’s in lost life and nursing care. A scientific panel refused to endorse the drug last year. The panel voted 8-1

The CEO of AMC (NYSE:AMC) recently argued that the company was helping its current shareholders by selling more shares of AMC stock. Source: Helen89 / Shutterstock.com “If I was a shareholder, I’d be more concerned that we don’t have shares available to us because I think shares are a very powerful tool to do good

Here’s a little-known stat. American summer camps import approximately 25,000 counselors each summer through the J-1 visa cultural exchange program. Like many industries, camps are facing labor shortages this summer. If I were aware of a publicly traded camp company, it would be on my list of stocks to avoid.  Other industries expected to have

BlackBerry (NYSE:BB) stock often rises meteorically and then crashes quickly. That’s what has happened recently to the shares of the Canadian company that was once known for its phones and is now focused on security software.  Source: Paul McKinnon/Shutterstock.com BB stock doubled between June 1 and June 3, spiking above $20 at 9:30 am on

Given the tense environment surrounding EVs, I’m not going to reveal how I really feel about QuantumScape (NYSE:QS) stock. Source: Michael Vi / Shutterstock.com Electric vehicles are the future, period, and may you rot in perdition if you believe otherwise (at least that’s what the popular mantra is these days). By those lights, I should

Bull markets often make investors act out of character. This phenomenon is currently playing out with the Reddit “meme stocks,” in particular Naked Brands (NASDAQ:NAKD). At one point this year, NAKD stock “soared” to a price of $1.65 per share. Source: Shutterstock However, investors familiar with Naked Brands might recall this company spent most of 2020

For the past decade, Northern Dynasty (NYSEAMERICAN:NAK) stock has been one of the larger gold mining juniors out there. Source: allstars / Shutterstock.com The company has long sought to develop its Pebble property into a working gold mine. In recent years, the price of gold cooperated as well. As gold surged, it seemed increasingly as if

With the negative news continuing to pile up for Ocugen (NASDAQ:OCGN) stock, the case against the shares has become almost as strong as an Olympic weightlifting champion. OCGN stock is down more than 44% in the last month. Source: Shutterstock Among the latest, most critical negative developments for the company are the fact that Pfizer’s

Hopeful investors gave up in the weeks that followed QuantumScape’s (NYSE:QS) quarterly results. QS stock tried to bounce back to above the $30 range last month but failed. Source: Michael Vi/Shutterstock.com Investors cannot get over the higher capital expenses ahead. Though liquidity fueled the stock after its post-SPAC (special purpose acquisition company) status, reality weighs

Special Purpose Acquisition Companies (SPACs) are falling out of vogue and Lordstown Motors (NASDAQ:RIDE) is no exception. Source: Postmodern Studio / Shutterstock.com The stock peaked at $31.80 back in February before falling when the Nasdaq index broke down. Bears, too, are all over RIDE stock, with a short interest of 30.82%. An ugly quarterly earnings

Most of Wall Street underestimates the impact of cord cutting and overestimates the extent companies can compensate with internet streaming channels. As a result, most of the Street was shocked by AT&T’s (NYSE:T) decision to unload WarnerMedia for a relatively low amount of money, triggering a sizeable downturn in T stock. I believe that Disney

Today we’re going to touch on one of my favorite topics, which is science fiction. As technology evolves, it is becoming more science than fiction, and we are almost there. The opportunity to profit from exploring space is as real as ever. Virgin Galactic (NYSE:SPCE) is a major commercial space travel company trading publicly. But trading

Swedish plant-based milk company Oatly (NASDAQ:OTLY) recently had its blockbuster IPO, which saw its valuation skyrocketing over $10 billion. There’s a lot to like about OTLY stock, as it looks to create a more sustainable product and lead the way in the global dairy market worth more than $700 billion. It’s been around for the

The latest news that Ocugen (NASDAQ:OCGN) is moving closer toward emergency use authorization for its Covid-19 vaccine candidate is moving its stock. On May 25 the company submitted its master file to the Food and Drug Administration as part of the emergency use authorization (EUA) process.  Source: Shutterstock But many obstacles remain for Ocugen. The first

With Airbnb (NASDAQ:ABNB) unlikely to benefit from the reopening of economies as much as conventional hotels and still facing multiple other challenges, I continue to recommend selling ABNB stock. Source: BigTunaOnline / Shutterstock.com Further, the shares’ extremely high valuation compared to other names in the lodging sector makes me wary of recommending the name at

Just when I thought there might be a nice orderly selloff of GameStop (NYSE:GME) stock, the Reddit crowd is back at it. In the 30 days ending June 1, GME stock jumped 53%. And the only explanation that seems to fit is that the Reddit crowd simply loves to pump up heavily shorted stocks.   Source: Shutterstock

Just because the business of AMC Entertainment (NYSE:AMC) remains fundamentally unchanged doesn’t mean that AMC stock should stagnate. That much was proven to be true on May 28, when the “meme stock” rocketed upward again, reaching a high of $36.72. Source: rblfmr / Shutterstock.com However, this particular run up in AMC stock was fundamentally different

Carnival (NYSE:CCL) stock is up 36% this year, showing some signs of life. But Carnival is still a very risky company that’s operating in a very risky industry. Source: Ruth Peterkin / Shutterstock.com In an effort to squeeze out a few months of sailing during the traditional summer season, cruise lines are rolling out their

Virgin Galactic (NYSE:SPCE) stock has had a wild year thus far. But, of course wild swings are to be expected, especially considering SPCE stock operates in the space exploration industry. Source: rafapress / Shutterstock.com This industry has never been hotter, thanks to billionaires who’ve zeroed in on it as another high-growth sector. Richard Branson, Elon Musk

Because the novel coronavirus pandemic has more twists and turns than the Monaco Grand Prix, my take on biotechnology firm Ocugen (NASDAQ:OCGN) stock has been admittedly all over the map. Source: Shutterstock Still, it’s very possible that the recent volatility in OCGN stock finally provided some much-needed clarity. First, let’s back up for a moment.

After investigating Palantir (NYSE:PLTR) further, I’ve found more reasons to be worried about PLTR stock. Despite the company’s large year-over-year (YOY) growth rates in the first quarter, there are signs that Palantir’s top-line expansion is stagnating. Its net losses rapidly increased on a YOY basis last quarter and in all of 2020. Source: Sundry Photography

Since the start of May, Covid-19 vaccine play Ocugen (NASDAQ:OCGN) stock is down around 50%. But the company has made some progress in bringing Covaxin, developed in India by Bharat Biotech, to the U.S. market. So, are things back on track? Source: Shutterstock Yes and no. Sure, the company now has a set date (June)